Bionime Profit Margin

Bionime (4737.TW) currently reports a profit margin of -16.62% as of June 2026. That compares with -5.85% in the prior-year period — down 184.1% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Bionime's profit margin history and peer comparisons.

Bionime's profit margin decreased from -5.85% to -16.62% — a 184.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bionime's profit margin of -16.62% is lower than the its sector sector average of 13.23%. That is roughly 225.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bionime's current -16.62% should be judged against industry norms (sector average: 13.23%) and against 4737.TW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -16.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Bionime, and consider following 4737.TW for alerts when major investors trade the stock.